Home » Biotechnology » Global High Throughput Process Development Market

Global High Throughput Process Development Market By Product (Consumables and Reagents and Instruments), By Process (Upstream and Downstream), By Molecule Type (Monoclonal Antibodies, Vaccines, Recombinant Insulin, Human Growth Hormones and Others) – Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 12656 | Report Format : PDF

For the purpose of this study, the various products studied include consumables, reagents, and instruments. The processes are classified as upstream and downstream.

Based on molecule type, this market is further segmented as monoclonal antibodies, vaccines, recombinant insulin, human growth hormones, and others. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

  • The geographic segmentation of the global high-throughput process development market is performed for the regions of North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global high-throughput process development market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global high throughput process development market. The major players in the high-throughput process development market are Agilent Technologies, Inc., Axxam S.P.A., Aurora Biomed, Bio-Rad Laboratories, Inc., Danaher Corporation, Hamilton Company, Merck Millipore Corporation, Perkin Elmer, Inc., Tecan Group Ltd., and Thermo Fisher Scientific, Inc.

Based on molecule type, the global high-throughput process development market is categorized into

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Insulin
  • Human Growth Hormone
  • Others

High-throughput process development is of prime importance, as there is a tantamount requirement for a robust, reproducible manufacturing process in the life science industries, as it is a critical pathway for the development of novel therapies. In order to meet regulatory requirements and technical challenges, a very good understanding of the critical processes and multiparameter involved in high-throughput process development is mandatory. In 2016, the monoclonal antibodies segment dominated the market mainly due to factors such as the rising adoption of targeted immunotherapy, the fact that they are a highly reproducible, scalable, and unlimited production source, and the fact that hybridomas serve as an immortal source for the production of monoclonal antibodies. The limitations of monoclonal antibodies are that the system is well developed for only mouse and rat models and not for other animals, and the USFDA stipulates that monoclonal antibodies intended for human use should be totally free from pathogens, including viruses. The vaccines segment is anticipated to register faster growth throughout the forecast period of 2017–2025, primarily due to the rising incidence of contagious diseases spread by vectors such as parasites, bacteria, and viruses and because vaccines are helpful in preventing the greater cost incurred during the treatment of infectious disease.

Based on process types, the global high-throughput process development market is categorized into:

  • Upstream
  • Downstream

In the current regulatory scenario, it often takes around a decade and a huge amount of money to promote a drug candidate from the development process to the shelves. There is a strong impetus for pursuing methodologies that can shorten this gap in process development and manufacturing. In 2016, the upstream segment held the largest market share, chiefly due to factors such as technological advancement in the production and development of biological drugs, a strong impetus from novel biotherapeutic clinical trials, optimization of growth kinetics for enhanced product development, and improvement in the inoculum by genetic engineering.

Downstream will be the fastest-growing segment throughout the forecast period of 2017–2025. Factors supporting the growth of this segment include technological advancement in the separation of biomass from the fermented broth by centrifugation and ultracentrifugation techniques and stringent regulatory guidelines stipulated by the USFDA, making it extremely important for the effective purification of active metabolites as there have been several incidents reported regarding biological drug-related serious adverse events.

Based on product types, the global high-throughput process development market is categorized into:

  • Consumables and Reagents
  • Instruments

The high-throughput process development market is driven by factors such as the rising prevalence of chronic diseases, an aging population, and the burgeoning requirement for the launch of novel drugs to counteract the multiple drug resistance of bacterial infections. In addition, an increasing number of diagnostic centers and growing physician awareness regarding disease etiology will propel market penetration for high-throughput screening. In 2016, the instruments segment held the largest market share, chiefly due to factors such as technological advancement in automation techniques and their huge application in biopharmaceuticals, contract research organizations, research institutes, etc.

Consumables and reagents will be the fastest-growing segment throughout the forecast period of 2017–2025, primarily due to factors such as the rising prevalence of chronic diseases, steadily increasing diagnostic centers, and public-private partnerships to combat life-threatening diseases by setting up research and development centers. The major players in the high-throughput screening market are Agilent Technologies, Inc., Axxam S.P.A., Aurora Biomed, Bio-Rad Laboratories, Inc., Danaher Corporation, Hamilton Company, Merck Millipore Corporation, Perkin Elmer, Inc., Tecan Group Ltd., and Thermo Fisher Scientific, Inc.

For the purpose of this study, the global high-throughput process development market is categorized into the following regional and country-specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of the Middle East and Africa

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

In the base year 2016, North America was observed to be the largest market for high-throughput process development. The dominance of North America is mainly attributed to the presence of major giants in the biotechnology and pharmaceutical industries, which focus on the novel drug discovery of biological drug candidates and the existence of advanced healthcare and research facilities. The market growth in Europe is mainly attributed to the increasing number of patients suffering from chronic diseases. This factor boosts demand for lowering the manufacturing cost of biological drugs and reducing product development timelines. Asia Pacific was observed as the fastest-growing regional segment throughout the forecast period of 2017–2025. The presence of a large patient pool that can be enrolled to study the safety and efficacy studies for biological drug candidates during clinical trials, as well as increased research and development spending by governmental organizations, are expected to propel market growth in Asia-Pacific. Moreover, factors such as developing healthcare infrastructure and public-private partnerships between major biopharmaceutical players and academic research institutes are going to fuel the rapid growth of the high-throughput process development market in Latin America, the Middle East, and Africa in the near future.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global High Throughput Process Development Market Portraiture
2.1.1. Global High Throughput Process Development Market, by Product, 2016
2.1.2. Global High Throughput Process Development Market, by Process, 2016
2.1.3. Global High Throughput Process Development Market, by Molecule Type, 2016
2.1.4. Global High Throughput Process Development Market, by Geography, 2016

Chapter 3. High Throughput Process Development: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global High Throughput Process Development Market, by Product
4.3. Consumables and Reagents
4.4. Instruments

Chapter 5. Global High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Upstream
5.3. Downstream

Chapter 6. Global High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Monoclonal Antibodies
6.3. Vaccines
6.4. Recombinant Insulin
6.5. Human Growth Hormones
6.6. Others

Chapter 7. Global High Throughput Process Development Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America High Throughput Process Development Market Analysis, 2015 – 2025
7.2.1. North America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.2.2. North America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.2.3. North America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.2.4. North America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe High Throughput Process Development Market Analysis, 2015 – 2025
7.3.1. Europe High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.3.2. Europe High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.3.3. Europe High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.3.4. Europe High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific High Throughput Process Development Market Analysis, 2015 – 2025
7.4.1. Asia Pacific High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America High Throughput Process Development Market Analysis, 2015 – 2025
7.5.1. Latin America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.5.2. Latin America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.5.3. Latin America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.5.4. Latin America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) High Throughput Process Development Market Analysis, 2015 – 2025
7.6.1. MEA High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.6.2. MEA High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.6.3. MEA High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.6.4. MEA High Throughput Process Development Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Agilent Technologies, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Axxam S.P.A.
8.3. Aurora Biomed
8.4. Bio-Rad Laboratories, Inc.
8.5. Danaher Corporation
8.6. Hamilton Company
8.7. Merck Millipore Corporation
8.8. Perkin Elmer, Inc.
8.9. Tecan Group Ltd.
8.10. Thermo Fisher Scientific, Inc.

List of Figures

FIG. 1 High Throughput Process Development: Market Segmentation
FIG. 2 Global High Throughput Process Development Market Share, by Product, 2016 (Value %)
FIG. 3 Global High Throughput Process Development Market Share, by Process, 2016 (Value %)
FIG. 4 Global High Throughput Process Development Market Share, by Molecule Type, 2016 (Value %)
FIG. 5 Global High Throughput Process Development Market Share, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global High Throughput Process Development Consumables and Reagents Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global High Throughput Process Development Instruments Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Upstream High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Downstream High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Monoclonal Antibodies Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 13 Global Vaccines Market for High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Recombinant Insulin Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 15 Global Human Growth Hormone Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 16 Global Other Molecule Types Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 17 U.S. High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 18 Canada High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 19 U.K. High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 20 Germany High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 21 Rest of Europe High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 22 Japan High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 23 China High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 24 India High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Asia Pacific High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 26 Brazil High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 27 Mexico High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Latin America High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 29 GCC High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 30 Rest of Middle East and Africa High Throughput Process Development Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 3 Global High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 4 Global High Throughput Process Development Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 6 North America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 7 North America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 8 North America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Europe High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 11 Europe High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa High Throughput Process Development Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 25 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Axxam S.P.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Aurora Biomed: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Hamilton Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Merck Millipore Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Perkin Elmer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Tecan Group Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions

What is the size of High Throughput Process Development Market?

The market for High Throughput Process Development is expected to reach US$ 24,600.7 Mn in 2025.

What is the High Throughput Process Development Market CAGR?

The High Throughput Process Development market is expected to see significant CAGR growth over the coming years,at 9.55%

What is the Forecast period considered for High Throughput Process Development Market?

The report is forecasted from 2017-2025

What is the base year considered for High Throughput Process Development Market?

The base year of this report is 2016.

Who are the major players in this Market?

Agilent Technologies, Inc.,Axxam S.P.A.,Aurora Biomed,Bio-Rad Laboratories, Inc.,Danaher Corporation are some of the major players in the global market.

Tropical Disease Diagnostics Market

Published:
Report ID: 6276

U.S. Laboratory Electronic Balance Market

Published:
Report ID: 41634

Australia Laboratory Electronic Balance Market

Published:
Report ID: 41603

India Laboratory Electronic Balance Market

Published:
Report ID: 41537

Bioreactors Market

Published:
Report ID: 40980

Allogeneic Cell Therapy Market

Published:
Report ID: 40680

Bioreactors and Fermenters Market

Published:
Report ID: 40664

Aseptic Fill Finish Market

Published:
Report ID: 40669

Digital PCR Market

Published:
Report ID: 12323

In-Vitro ADME Services Market

Published:
Report ID: 11191

Europe Distributed Solar Power Generation Market

Published:
Report ID: 37132

Biotechnology Contract Manufacturing Market

Published:
Report ID: 36713

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN